Advertisement
Research Article

An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome

  • Benjamin L Ebert equal contributor,

    equal contributor Contributed equally to this work with: Benjamin L Ebert, Naomi Galili

    Affiliations: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, Brigham and Women's Hospital, Department of Medicine, Boston, Massachusetts, United States of America

    X
  • Naomi Galili equal contributor,

    equal contributor Contributed equally to this work with: Benjamin L Ebert, Naomi Galili

    Affiliation: St. Vincent's Comprehensive Cancer Center, New York, New York, United States of America

    X
  • Pablo Tamayo,

    Affiliation: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

    X
  • Jocelyn Bosco,

    Affiliations: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Raymond Mak,

    Affiliations: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Jennifer Pretz,

    Affiliations: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Shyam Tanguturi,

    Affiliation: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

    X
  • Christine Ladd-Acosta,

    Affiliation: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America

    X
  • Richard Stone,

    Affiliations: Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, Brigham and Women's Hospital, Department of Medicine, Boston, Massachusetts, United States of America

    X
  • Todd R Golub,

    Affiliations: Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, Childrens's Hospital, Boston, Massachusetts, United States of America, Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America

    X
  • Azra Raza mail

    To whom correspondence should be addressed. E-mail: araza@aptiumoncology.com

    Affiliation: St. Vincent's Comprehensive Cancer Center, New York, New York, United States of America

    X
  • Published: February 12, 2008
  • DOI: 10.1371/journal.pmed.0050035

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.